Medical Communications
Novo Nordisk Q1 operating profit down 10% in local currencies
April 29, 2016 Medical Communications, Sales and Marketing Financial, Novo Nordisk, Q1, earnings, outlook, results
Sanofi confirm 2016 outlook with Q1 results, EPS rises 5.3%
April 29, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2016, Q1, Sanofi, earnings, outlook, results
AstraZeneca Q1 earnings down 12%; maintains FY view
April 29, 2016 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Q!, earnings, outlook, profits, q, results
Amgen raises 2016 outlook after Q1 earnings boost
April 29, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, etanercept, financial results, financials, sales rise
AbbVie expands oncology portfolio with $5.8 billion Stemcentrx acquisition
April 29, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, acquisition, rova-t, stremcentrx, takeover
The mutual benefit of becoming one of Britain’s best workplaces
April 28, 2016 Medical Communications great place to work, medical communications, medical communications agency
World Immunisation Week marked by ABPI reception in House of Commons
April 28, 2016 Medical Communications ABPI, immunisations
Valeant’s outgoing boss tells Senate committee he “regrets” drug price rises
April 28, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Senate, Valeant, admits, aggressive, committee, drug price, pearson, rises
Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud
April 28, 2016 Medical Communications, Sales and Marketing False Claims Act, Medicaid, Pfizer, US, Wyeth, department, fraud, insurer, justice
Remaining in the EU is vital for UK’s cancer research strength, say leading oncologists
April 27, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, EU, Europe, UK, brexit, britain, cancer research, cede, exit, implications, negative, oncology, pharma
Valeant names Joseph Papa as new chief executive officer
April 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Chairman, Valeant, joseph papa, new, new ceo, papa, pearson
Valeant receives further default notices due to its delayed 10-K filing
April 25, 2016 Medical Communications, Sales and Marketing Valeant, default, risk, trouble, worry
AstraZeneca to sequence genomes to develop new drugs
April 22, 2016 Medical Communications, Sales and Marketing AstraZeneca, Finland, Wellcome Trust, collaboration, genome, genomics, human longevity, institute for molecular medicine, sanger institute
AbbVie announces further industry and academic collaborations
April 22, 2016 Medical Communications, Research and Development AbbVie, collaboration, commercialisation, cytomx, partnership, research, university of chicago
Biogen Q1 profits rise boosted by Tecfidera sales
April 22, 2016 Medical Communications, Sales and Marketing Biogen, Q1, biotech, earnings, results, tecfidera
Latest content
MedPharm appoints Jason Mieding as chief operating officer
Coriolis Pharma appoints Teun van der Heide as CEO
The evidence bar impacting UK medical cannabis access
